Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration

Journal of Biological Chemistry

Volumn 288, Issue 41, 2013, Pages 29890-29900

  Fu, Ping ^a   Yang, Zhiyong ^a   Bach, Leon A ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; AMINO ACIDS; BINDING ENERGY; CELL MEMBRANES; CELL PROLIFERATION; INSULIN; PROTEINS;

BINDING AFFINITIES; CO-IMMUNOPRECIPITATIONS; INDEPENDENT ACTION; INSULIN-LIKE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MOLECULAR MECHANISM; THERAPEUTIC TARGETS; TYROSINE PHOSPHORYLATION;

CYTOLOGY;

MITOGEN ACTIVATED PROTEIN KINASE; PROHIBITIN; PROHIBITIN 2; SOMATOMEDIN BINDING PROTEIN 6; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RHABDOMYOSARCOMA; SARCOMA CELL;

EID: 84885585103     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.510826     Document Type: Article

References (59)

1. Visser, M., Sijmons, C., Bras, J., Arceci, R. J., Godfried, M., Valentijn, L. J., Voûte, P. A., and Baas, F. (1997) Allelotype of pediatric rhabdomyosarcoma. Oncogene 15, 1309-1314
2. Barr, F. G. (2001) Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene 20, 5736-5746
3. Bach, L. A. (2005) IGFBP-6 five years on; not so "forgotten"? Growth Horm. IGF Res. 15, 185-192
4. Fu, P., Liang, G. J., Khot, S. S., Phan, R., and Bach, L. A. (2010) Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP- 6-induced Rh30 rhabdomyosarcoma cell migration. J. Cell Physiol. 224, 636-643
5. Fu, P., Thompson, J. A., and Bach, L. A. (2007) Promotion of cancer cell migration. An insulin-like growth factor (IGF)-independent action of IGF-binding protein-6. J. Biol. Chem. 282, 22298-22306
6. Mishra, S., Murphy, L. C., Nyomba, B. L., and Murphy, L. J. (2005) Prohibitin. A potential target for new therapeutics. Trends Mol. Med. 11, 192-197
7. Theiss, A. L., and Sitaraman, S. V. (2011) The role and therapeutic potential of prohibitin in disease. Biochim. Biophys. Acta 1813, 1137-1143
8. Osman, C., Merkwirth, C., and Langer, T. (2009) Prohibitins and the functional compartmentalization of mitochondrial membranes. J. Cell Sci. 122, 3823-3830
9. Artal-Sanz, M., and Tavernarakis, N. (2009) Prohibitin and mitochondrial biology. Trends Endocrinol. Metab. 20, 394-401
10. Wang, S., and Faller, D. V. (2008) Roles of prohibitin in growth control and tumor suppression in human cancers. Transl. Oncogenomics 3, 23-37
11. Rajalingam, K., and Rudel, T. (2005) Ras-Raf signaling needs prohibitin. Cell Cycle 4, 1503-1505
12. Héron-Milhavet, L., Mamaeva, D., Rochat, A., Lamb, N. J., and Fernandez, A. (2008) Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA. J. Cell Physiol. 214, 158-165
13. Emerson, V., Holtkotte, D., Pfeiffer, T., Wang, I. H., Schnölzer, M., Kempf, T., and Bosch, V. (2010) Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein. J. Virol. 84, 1355-1365
14. Sharma, A., and Qadri, A. (2004) Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc. Natl. Acad. Sci. U.S.A. 101, 17492-17497
15. Kuadkitkan, A., Wikan, N., Fongsaran, C., and Smith, D. R. (2010) Identification and characterization of prohibitin as a receptor protein mediating DENV-2 entry into insect cells. Virology 406, 149-161
16. McRobert, E. A., Gallicchio, M., Jerums, G., Cooper, M. E., and Bach, L. A. (2003) The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications. J. Biol. Chem. 278, 25783-25789
17. Strausberg, R. L., Feingold, E. A., Grouse, L. H., Derge, J. G., Klausner, R. D., Collins, F. S., Wagner, L., Shenmen, C. M., Schuler, G. D., Altschul, S. F., Zeeberg, B., Buetow, K. H., Schaefer, C. F., Bhat, N. K., Hopkins, R. F., Jordan, H., Moore, T., Max, S. I., Wang, J., Hsieh, F., Diatchenko, L., Marusina, K., Farmer, A. A., Rubin, G. M., Hong, L., Stapleton, M., Soares, M. B., Bonaldo, M. F., Casavant, T. L., Scheetz, T. E., Brownstein, M. J., Usdin, T. B., Toshiyuki, S., Carninci, P., Prange, C., Raha, S. S., Loquellano, N. A., Peters, G. J., Abramson, R. D., Mullahy, S. J., Bosak, S. A., McEwan, P. J., McKernan, K. J., Malek, J. A., Gunaratne, P. H., Richards, S., Worley, K. C., Hale, S., Garcia, A. M., Gay, L. J., Hulyk, S. W., Villalon, D. K., Muzny, D. M., Sodergren, E. J., Lu, X., Gibbs, R. A., Fahey, J., Helton, E., Ketteman, M., Madan, A., Rodrigues, S., Sanchez, A., Whiting, M., Young, A. C., Shevchenko, Y., Bouffard, G. G., Blakesley, R. W., Touchman, J. W., Green, E. D., Dickson, M. C., Rodriguez, A. C., Grimwood, J., Schmutz, J., Myers, R. M., Butterfield, Y. S., Krzywinski, M. I., Skalska, U., Smailus, D. E., Schnerch, A., Schein, J. E., Jones, S. J., and Marra, M. A. (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. U.S.A. 99, 16899-16903
18. Headey, S. J., Leeding, K. S., Norton, R. S., and Bach, L. A. (2004) Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding. J. Mol. Endocrinol. 33, 377-386
19. Mishra, S., Ande, S. R., and Nyomba, B. L. (2010) The role of prohibitin in cell signaling. FEBS J. 277, 3937-3946
20. Berger, K. H., and Yaffe, M. P. (1998) Prohibitin family members interact genetically with mitochondrial inheritance components in Saccharomyces cerevisiae. Mol. Cell Biol. 18, 4043-4052
21. Merkwirth, C., and Langer, T. (2009) Prohibitin function within mitochondria. Essential roles for cell proliferation and cristae morphogenesis. Biochim. Biophys. Acta 1793, 27-32
22. Sievers, C., Billig, G., Gottschalk, K., and Rudel, T. (2010) Prohibitins are required for cancer cell proliferation and adhesion. PLoS One 5, e12735
23. Chiu, C. F., Ho, M. Y., Peng, J. M., Hung, S. W., Lee, W. H., Liang, C. M., and Liang, S. M. (2013) Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane. Oncogene 32, 777-787
24. Bach, L. A. (1999) Insulin-like growth factor binding protein-6. The "forgotten" binding protein? Horm. Metab. Res. 31, 226-234
25. Martins, A. S., Olmos, D., Missiaglia, E., and Shipley, J. (2011) Targeting the insulin-like growth factor pathway in rhabdomyosarcomas. Rationale and future perspectives. Sarcoma 2011, 209736
26. Gallicchio, M. A., Kneen, M., Hall, C., Scott, A. M., and Bach, L. A. (2001) Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo. Int. J. Cancer 94, 645-651
27. Scholl, F. A., Betts, D. R., Niggli, F. K., and Schäfer, B. W. (2000) Molecular features of a human rhabdomyosarcoma cell line with spontaneous metastatic progression. Br. J. Cancer 82, 1239-1245
28. Iosef, C., Gkourasas, T., Jia, C. Y., Li, S. S., and Han, V. K. (2008) A functional nuclear localization signal in insulin-like growth factor binding protein- 6 mediates its nuclear import. Endocrinology 149, 1214-1226
29. Iosef, C., Vilk, G., Gkourasas, T., Lee, K. J., Chen, B. P., Fu, P., Bach, L. A., Lajoie, G., Gupta, M. B., Li, S. S., and Han, V. K. (2010) Insulin-like growth factor binding protein-6 (IGFBP-6) interacts with DNA-end binding protein Ku80 to regulate cell fate. Cell. Signal. 22, 1033-1043
30. Kokkinakis, D. M., Rushing, E. J., Shareef, M. M., Ahmed, M. M., Yang, S., Singha, U. K., and Luo, J. (2004) Physiology and gene expression characteristics of carcinogen-initiated and tumor-transformed glial progenitor cells derived from the CNS of methylnitrosourea (MNU)-treated Sprague-Dawley rats. J. Neuropathol. Exp. Neurol. 63, 1182-1199
31. Xu, X. F., Guo, C. Y., Liu, J., Yang, W. J., Xia, Y. J., Xu, L., Yu, Y. C., and Wang, X. P. (2009) Gli1 maintains cell survival by up-regulating IGFBP6 and Bcl-2 through promoter regions in parallel manner in pancreatic cancer cells. J. Carcinog. 8, 13
32. Velázquez-Fernandez, D., Laurell, C., Geli, J., Höög, A., Odeberg, J., Kjellman, M., Lundeberg, J., Hamberger, B., Nilsson, P., and Bäckdahl, M. (2005) Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery 138, 1087-1094
33. Nordqvist, A. C., and Mathiesen, T. (2002) Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness. J. Neurooncol. 57, 19-26
34. Firth, S. M., and Baxter, R. C. (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23, 824-854
35. Zhu, W., Shiojima, I., Ito, Y., Li, Z., Ikeda, H., Yoshida, M., Naito, A. T., Nishi, J., Ueno, H., Umezawa, A., Minamino, T., Nagai, T., Kikuchi, A., Asashima, M., and Komuro, I. (2008) IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. Nature 454, 345-349
36. Ingermann, A. R., Yang, Y. F., Han, J., Mikami, A., Garza, A. E., Mohanraj, L., Fan, L., Idowu, M., Ware, J. L., Kim, H. S., Lee, D. Y., and Oh, Y. (2010) Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer. J. Biol. Chem. 285, 30233-30246
37. Jones, J. I., Gockerman, A., Busby, W. H., Jr., Wright, G., and Clemmons, D. R. (1993) Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci. U.S.A. 90, 10553-10557
38. Schütt, B. S., Langkamp, M., Rauschnabel, U., Ranke, M. B., and Elmlinger, M. W. (2004) Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. J. Mol. Endocrinol. 32, 859-868
39. Merkwirth, C., Dargazanli, S., Tatsuta, T., Geimer, S., Löwer, B., Wunderlich, F. T., von Kleist-Retzow, J. C., Waisman, A., Westermann, B., and Langer, T. (2008) Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev. 22, 476-488
40. Yurugi, H., Tanida, S., Ishida, A., Akita, K., Toda, M., Inoue, M., and Nakada, H. (2012) Expression of prohibitins on the surface of activated T cells. Biochem. Biophys. Res. Commun. 420, 275-280
41. Terashima, M., Kim, K. M., Adachi, T., Nielsen, P. J., Reth, M., Köhler, G., and Lamers, M. C. (1994) The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J. 13, 3782-3792
42. Strub, G. M., Paillard, M., Liang, J., Gomez, L., Allegood, J. C., Hait, N. C., Maceyka, M., Price, M. M., Chen, Q., Simpson, D. C., Kordula, T., Milstien, S., Lesnefsky, E. J., and Spiegel, S. (2011) Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. FASEB J. 25, 600-612
43. Kasashima, K., Ohta, E., Kagawa, Y., and Endo, H. (2006) Mitochondrial functions and estrogen receptor-dependent nuclear translocation of pleiotropic human prohibitin 2. J. Biol. Chem. 281, 36401-36410
44. Kim, J. W., Akiyama, M., Park, J. H., Lin, M. L., Shimo, A., Ueki, T., Daigo, Y., Tsunoda, T., Nishidate, T., Nakamura, Y., and Katagiri, T. (2009) Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer. Cancer Sci. 100, 1468-1478
45. Sun, L., Liu, L., Yang, X. J., and Wu, Z. (2004) Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation. J. Cell Sci. 117, 3021-3029
46. Bacher, S., Achatz, G., Schmitz, M. L., and Lamers, M. C. (2002) Prohibitin and prohibitone are contained in high-molecular weight complexes and interact with α-actinin and annexin A2. Biochimie 84, 1207-1220
47. Ross, J. A., Nagy, Z. S., and Kirken, R. A. (2008) The PHB1/2 phosphocomplex is required for mitochondrial homeostasis and survival of human T cells. J. Biol. Chem. 283, 4699-4713
48. Ande, S. R., Gu, Y., Nyomba, B. L., and Mishra, S. (2009) Insulin induced phosphorylation of prohibitin at tyrosine 114 recruits Shp1. Biochim. Biophys. Acta 1793, 1372-1378
49. Ande, S. R., Moulik, S., and Mishra, S. (2009) Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin. Implication for a novel binary switch. PLoS One 4, e4586
50. Ande, S. R., and Mishra, S. (2009) Prohibitin interacts with phosphatidylinositol 3,4,5-triphosphate (PIP3) and modulates insulin signaling. Biochem. Biophys. Res. Commun. 390, 1023-1028
51. Chiu, C. F., Peng, J. M., Hung, S. W., Liang, C. M., and Liang, S. M. (2012) Recombinant viral capsid protein VP1 suppresses migration and invasion of human cervical cancer by modulating phosphorylated prohibitin in lipid rafts. Cancer Lett. 320, 205-214
52. Fukasawa, H., Obayashi, H., Schmieder, S., Lee, J., Ghosh, P., and Farquhar, M. G. (2011) Phosphorylation of podocalyxin (Ser415) Prevents RhoA and ezrin activation and disrupts its interaction with the actin cytoskeleton. Am. J. Pathol. 179, 2254-2265
53. Rajalingam, K., Wunder, C., Brinkmann, V., Churin, Y., Hekman, M., Sievers, C., Rapp, U. R., and Rudel, T. (2005) Prohibitin is required for Rasinduced Raf-MEK-ERK activation and epithelial cell migration. Nat. Cell Biol. 7, 837-843
54. Zhu, B., Fukada, K., Zhu, H., and Kyprianou, N. (2006) Prohibitin and cofilin are intracellular effectors of transforming growth factorβ signaling in human prostate cancer cells. Cancer Res. 66, 8640-8647
55. Zhu, B., Zhai, J., Zhu, H., and Kyprianou, N. (2010) Prohibitin regulates TGF-β induced apoptosis as a downstream effector of Smad-dependent and -independent signaling. Prostate 70, 17-26
56. Ponce, J., Brea, D., Carrascal, M., Guirao, V., Degregorio-Rocasolano, N., Sobrino, T., Castillo, J., Dávalos, A., and Gasull, T. (2010) The effect of simvastatin on the proteome of detergent-resistant membrane domains. Decreases of specific proteins previously related to cytoskeleton regulation, calcium homeostasis and cell fate. Proteomics 10, 1954-1965
57. Mengwasser, J., Piau, A., Schlag, P., and Sleeman, J. P. (2004) Differential immunization identifies PHB1/PHB2 as blood-borne tumor antigens. Oncogene 23, 7430-7435
58. Ande, S. R., Xu, Z., Gu, Y., and Mishra, S. (2012) Prohibitin has an important role in adipocyte differentiation. Int. J. Obes. 36, 1236-1244
59. Zhang, C., Lu, L., Li, Y., Wang, X., Zhou, J., Liu, Y., Fu, P., Gallicchio, M. A., Bach, L. A., and Duan, C. (2012) IGF binding protein-6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis. Int. J. Cancer 130, 2003-2012